 James Liu
Concepts (274)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Estrogens | 9 | 2020 | 367 | 2.560 |
Why?
| | Postmenopause | 8 | 2021 | 366 | 1.680 |
Why?
| | Leiomyoma | 3 | 2021 | 77 | 1.350 |
Why?
| | Norpregnadienes | 2 | 2021 | 7 | 1.330 |
Why?
| | Estradiol | 6 | 2021 | 521 | 1.290 |
Why?
| | Estrogen Replacement Therapy | 8 | 2020 | 146 | 1.280 |
Why?
| | Pituitary Neoplasms | 4 | 2024 | 190 | 1.180 |
Why?
| | Vaginal Creams, Foams, and Jellies | 2 | 2018 | 4 | 1.140 |
Why?
| | Dyspareunia | 2 | 2018 | 8 | 1.140 |
Why?
| | Vulva | 2 | 2018 | 24 | 1.130 |
Why?
| | Adenoma | 3 | 2024 | 230 | 1.060 |
Why?
| | Skull Base Neoplasms | 4 | 2024 | 30 | 1.050 |
Why?
| | Vagina | 4 | 2021 | 187 | 1.030 |
Why?
| | Cranial Sinuses | 1 | 2024 | 15 | 0.880 |
Why?
| | Neuroma, Acoustic | 2 | 2022 | 51 | 0.850 |
Why?
| | Ovary | 4 | 2020 | 221 | 0.820 |
Why?
| | Intracranial Arteriovenous Malformations | 1 | 2023 | 50 | 0.790 |
Why?
| | Ovarian Neoplasms | 3 | 2020 | 565 | 0.720 |
Why?
| | Contraceptive Devices, Female | 1 | 2021 | 10 | 0.710 |
Why?
| | Pregnenediones | 1 | 2021 | 19 | 0.710 |
Why?
| | Hydrocarbons, Fluorinated | 1 | 2020 | 9 | 0.670 |
Why?
| | Microvascular Decompression Surgery | 1 | 2020 | 6 | 0.670 |
Why?
| | Trigeminal Nerve | 1 | 2020 | 27 | 0.670 |
Why?
| | Hormone Antagonists | 1 | 2020 | 34 | 0.670 |
Why?
| | Trigeminal Neuralgia | 1 | 2020 | 18 | 0.660 |
Why?
| | Menopause, Premature | 1 | 2020 | 12 | 0.660 |
Why?
| | Uterine Neoplasms | 2 | 2018 | 109 | 0.660 |
Why?
| | Salpingo-oophorectomy | 1 | 2020 | 18 | 0.660 |
Why?
| | Antineoplastic Agents, Hormonal | 2 | 2018 | 161 | 0.640 |
Why?
| | Bacteriophages | 1 | 2021 | 98 | 0.630 |
Why?
| | Brain Neoplasms | 3 | 2025 | 1238 | 0.610 |
Why?
| | Frailty | 1 | 2022 | 170 | 0.610 |
Why?
| | Neurosurgical Procedures | 5 | 2024 | 197 | 0.600 |
Why?
| | Uterine Hemorrhage | 1 | 2018 | 37 | 0.590 |
Why?
| | Gonadotropin-Releasing Hormone | 1 | 2020 | 212 | 0.590 |
Why?
| | Androgen Antagonists | 1 | 2019 | 82 | 0.590 |
Why?
| | Breast Neoplasms | 2 | 2020 | 2253 | 0.560 |
Why?
| | Vaginal Diseases | 1 | 2017 | 21 | 0.560 |
Why?
| | Thyrotropin | 1 | 2018 | 114 | 0.560 |
Why?
| | Hysterectomy | 2 | 2018 | 129 | 0.550 |
Why?
| | Hypothyroidism | 1 | 2018 | 72 | 0.550 |
Why?
| | Osteoporosis | 1 | 2020 | 243 | 0.550 |
Why?
| | Glioblastoma | 1 | 2021 | 345 | 0.540 |
Why?
| | Pyrimidines | 1 | 2020 | 470 | 0.520 |
Why?
| | Cardiovascular System | 1 | 2018 | 137 | 0.510 |
Why?
| | Testosterone | 2 | 2019 | 409 | 0.490 |
Why?
| | Transgender Persons | 1 | 2019 | 186 | 0.490 |
Why?
| | Endoscopy | 3 | 2019 | 318 | 0.480 |
Why?
| | Skull Base | 3 | 2022 | 53 | 0.470 |
Why?
| | Humans | 51 | 2025 | 137585 | 0.470 |
Why?
| | Polycystic Ovary Syndrome | 1 | 2018 | 177 | 0.470 |
Why?
| | Female | 36 | 2025 | 73304 | 0.460 |
Why?
| | Double-Blind Method | 6 | 2021 | 1993 | 0.420 |
Why?
| | Lipids | 1 | 2018 | 672 | 0.410 |
Why?
| | Pneumocephalus | 1 | 2013 | 4 | 0.410 |
Why?
| | Postoperative Complications | 4 | 2024 | 2654 | 0.400 |
Why?
| | Treatment Outcome | 9 | 2024 | 10811 | 0.400 |
Why?
| | Reproductive Medicine | 1 | 2012 | 15 | 0.380 |
Why?
| | Estrogens, Conjugated (USP) | 1 | 2012 | 49 | 0.370 |
Why?
| | Menopause | 4 | 2020 | 320 | 0.360 |
Why?
| | Endocrinology | 1 | 2012 | 79 | 0.350 |
Why?
| | Hot Flashes | 1 | 2012 | 87 | 0.350 |
Why?
| | Atrophy | 4 | 2021 | 184 | 0.340 |
Why?
| | Sleep Deprivation | 1 | 2012 | 174 | 0.320 |
Why?
| | Intraoperative Complications | 2 | 2023 | 138 | 0.320 |
Why?
| | Meningioma | 2 | 2021 | 91 | 0.290 |
Why?
| | Middle Aged | 15 | 2025 | 33479 | 0.280 |
Why?
| | Blood Glucose | 1 | 2018 | 2186 | 0.280 |
Why?
| | Meningeal Neoplasms | 2 | 2021 | 100 | 0.280 |
Why?
| | Insulin | 1 | 2018 | 2409 | 0.270 |
Why?
| | Gonadotropins, Pituitary | 1 | 2007 | 22 | 0.270 |
Why?
| | Ovarian Hyperstimulation Syndrome | 1 | 2007 | 7 | 0.270 |
Why?
| | Adult | 17 | 2025 | 37929 | 0.260 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2018 | 560 | 0.250 |
Why?
| | Moyamoya Disease | 1 | 2025 | 20 | 0.240 |
Why?
| | Aspartic Acid Endopeptidases | 1 | 2025 | 29 | 0.240 |
Why?
| | Follicle Stimulating Hormone | 1 | 2007 | 244 | 0.240 |
Why?
| | Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2025 | 31 | 0.230 |
Why?
| | Administration, Intravaginal | 4 | 2021 | 16 | 0.230 |
Why?
| | Gynatresia | 2 | 2020 | 2 | 0.230 |
Why?
| | Amyloid Precursor Protein Secretases | 1 | 2025 | 80 | 0.230 |
Why?
| | Neuroendoscopy | 1 | 2024 | 23 | 0.220 |
Why?
| | Jugular Veins | 1 | 2024 | 41 | 0.220 |
Why?
| | CRISPR-Cas Systems | 1 | 2025 | 125 | 0.220 |
Why?
| | Microsurgery | 1 | 2024 | 75 | 0.210 |
Why?
| | Drainage | 2 | 2015 | 173 | 0.200 |
Why?
| | Craniotomy | 1 | 2023 | 77 | 0.200 |
Why?
| | Denervation | 1 | 2022 | 24 | 0.190 |
Why?
| | Pheochromocytoma | 1 | 2023 | 59 | 0.190 |
Why?
| | Insulin Resistance | 2 | 2023 | 1208 | 0.190 |
Why?
| | Paraganglioma | 1 | 2023 | 52 | 0.190 |
Why?
| | Health Status Disparities | 1 | 2025 | 289 | 0.190 |
Why?
| | Wakefulness | 1 | 2023 | 125 | 0.190 |
Why?
| | Adrenal Gland Neoplasms | 1 | 2023 | 89 | 0.190 |
Why?
| | Cell Line, Tumor | 4 | 2025 | 3412 | 0.190 |
Why?
| | Progesterone | 2 | 2021 | 254 | 0.180 |
Why?
| | Cerebral Veins | 1 | 2021 | 16 | 0.180 |
Why?
| | Risk Factors | 5 | 2022 | 10388 | 0.180 |
Why?
| | Ethinyl Estradiol | 1 | 2021 | 16 | 0.180 |
Why?
| | Endometrium | 2 | 2015 | 58 | 0.180 |
Why?
| | Tumor Microenvironment | 1 | 2025 | 674 | 0.170 |
Why?
| | Phytoestrogens | 1 | 2020 | 17 | 0.170 |
Why?
| | Selective Estrogen Receptor Modulators | 1 | 2020 | 29 | 0.170 |
Why?
| | Pregnancy | 6 | 2021 | 6763 | 0.170 |
Why?
| | Contraceptive Agents | 1 | 2021 | 66 | 0.170 |
Why?
| | Hysteroscopy | 1 | 2020 | 12 | 0.170 |
Why?
| | Genes, BRCA2 | 1 | 2020 | 31 | 0.170 |
Why?
| | Aged | 8 | 2025 | 23961 | 0.160 |
Why?
| | Genes, BRCA1 | 1 | 2020 | 40 | 0.160 |
Why?
| | Drug Combinations | 1 | 2021 | 343 | 0.160 |
Why?
| | Reproductive Techniques, Assisted | 1 | 2020 | 37 | 0.160 |
Why?
| | Histones | 1 | 2025 | 636 | 0.160 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2023 | 279 | 0.160 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2021 | 172 | 0.160 |
Why?
| | Neuroprotection | 1 | 2019 | 42 | 0.160 |
Why?
| | Seizures | 1 | 2023 | 426 | 0.160 |
Why?
| | Neutrophils | 1 | 2025 | 1238 | 0.160 |
Why?
| | Body Mass Index | 2 | 2018 | 2389 | 0.160 |
Why?
| | History, 21st Century | 1 | 2020 | 213 | 0.160 |
Why?
| | Otorhinolaryngologic Surgical Procedures | 1 | 2019 | 40 | 0.150 |
Why?
| | Hormone Replacement Therapy | 2 | 2020 | 100 | 0.150 |
Why?
| | Complementary Therapies | 1 | 2020 | 88 | 0.150 |
Why?
| | History, 20th Century | 1 | 2020 | 325 | 0.150 |
Why?
| | Amenorrhea | 1 | 2018 | 31 | 0.150 |
Why?
| | Retrospective Studies | 5 | 2025 | 15657 | 0.150 |
Why?
| | Umbilicus | 1 | 2018 | 18 | 0.150 |
Why?
| | Pruritus Vulvae | 1 | 2018 | 1 | 0.140 |
Why?
| | Candidiasis, Vulvovaginal | 1 | 2018 | 4 | 0.140 |
Why?
| | Cerebrospinal Fluid Leak | 2 | 2017 | 62 | 0.140 |
Why?
| | Ohio | 1 | 2018 | 152 | 0.140 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2021 | 455 | 0.140 |
Why?
| | Administration, Oral | 1 | 2020 | 816 | 0.140 |
Why?
| | Receptors, Progesterone | 2 | 2021 | 350 | 0.140 |
Why?
| | Administration, Topical | 1 | 2018 | 151 | 0.140 |
Why?
| | Symptom Assessment | 1 | 2018 | 128 | 0.140 |
Why?
| | Sinus Pericranii | 1 | 2016 | 1 | 0.130 |
Why?
| | Superior Sagittal Sinus | 1 | 2016 | 4 | 0.130 |
Why?
| | Transverse Sinuses | 1 | 2016 | 8 | 0.130 |
Why?
| | Machine Learning | 1 | 2022 | 493 | 0.130 |
Why?
| | Central Nervous System Neoplasms | 1 | 2019 | 156 | 0.130 |
Why?
| | Neoplastic Stem Cells | 1 | 2021 | 399 | 0.130 |
Why?
| | Glucose Tolerance Test | 1 | 2018 | 366 | 0.130 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2025 | 1081 | 0.130 |
Why?
| | Cross-Over Studies | 1 | 2018 | 564 | 0.130 |
Why?
| | Laparoscopy | 2 | 2018 | 466 | 0.130 |
Why?
| | Robotic Surgical Procedures | 1 | 2018 | 130 | 0.120 |
Why?
| | Nuclear Proteins | 1 | 2021 | 712 | 0.120 |
Why?
| | Decorin | 1 | 2015 | 7 | 0.120 |
Why?
| | Surgical Flaps | 2 | 2017 | 130 | 0.120 |
Why?
| | Male | 8 | 2025 | 67762 | 0.120 |
Why?
| | Minimally Invasive Surgical Procedures | 1 | 2017 | 179 | 0.120 |
Why?
| | Cell Proliferation | 2 | 2021 | 2475 | 0.120 |
Why?
| | Algorithms | 2 | 2015 | 1704 | 0.120 |
Why?
| | Peritoneum | 1 | 2015 | 44 | 0.120 |
Why?
| | Myometrium | 1 | 2015 | 39 | 0.120 |
Why?
| | Decision Making, Computer-Assisted | 1 | 2015 | 18 | 0.120 |
Why?
| | Natural Orifice Endoscopic Surgery | 1 | 2015 | 34 | 0.120 |
Why?
| | Proteoglycans | 1 | 2015 | 107 | 0.120 |
Why?
| | Diagnosis, Differential | 2 | 2011 | 1483 | 0.110 |
Why?
| | Product Labeling | 1 | 2014 | 10 | 0.110 |
Why?
| | Endometriosis | 1 | 2015 | 51 | 0.110 |
Why?
| | Biomarkers | 2 | 2018 | 4149 | 0.110 |
Why?
| | Follow-Up Studies | 1 | 2023 | 5131 | 0.100 |
Why?
| | Young Adult | 4 | 2025 | 13209 | 0.100 |
Why?
| | Age Factors | 2 | 2018 | 3295 | 0.100 |
Why?
| | Optic Chiasm | 1 | 2013 | 18 | 0.100 |
Why?
| | Cerebral Ventricles | 1 | 2013 | 52 | 0.100 |
Why?
| | Infertility, Female | 2 | 2020 | 108 | 0.100 |
Why?
| | Risk Assessment | 1 | 2022 | 3457 | 0.100 |
Why?
| | Fertility Agents, Female | 1 | 2012 | 20 | 0.100 |
Why?
| | Triptorelin Pamoate | 1 | 2012 | 19 | 0.100 |
Why?
| | Mobile Applications | 1 | 2015 | 183 | 0.090 |
Why?
| | Chorionic Gonadotropin | 1 | 2012 | 80 | 0.090 |
Why?
| | Pregnancy, Ectopic | 1 | 2012 | 53 | 0.090 |
Why?
| | Primary Ovarian Insufficiency | 1 | 2012 | 38 | 0.090 |
Why?
| | Lung Neoplasms | 1 | 2025 | 2526 | 0.090 |
Why?
| | Melanoma | 1 | 2019 | 760 | 0.090 |
Why?
| | Cognition | 1 | 2019 | 1153 | 0.090 |
Why?
| | Vasomotor System | 1 | 2012 | 47 | 0.090 |
Why?
| | Cross-Sectional Studies | 3 | 2018 | 5472 | 0.090 |
Why?
| | Spermatocidal Agents | 1 | 2010 | 7 | 0.090 |
Why?
| | Nonoxynol | 1 | 2010 | 4 | 0.090 |
Why?
| | Weight Reduction Programs | 1 | 2012 | 117 | 0.090 |
Why?
| | Betaine | 1 | 2010 | 73 | 0.080 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2010 | 99 | 0.080 |
Why?
| | Severity of Illness Index | 1 | 2018 | 2828 | 0.080 |
Why?
| | Nose | 2 | 2022 | 67 | 0.070 |
Why?
| | Reference Values | 2 | 2020 | 816 | 0.070 |
Why?
| | Surveys and Questionnaires | 2 | 2018 | 5778 | 0.070 |
Why?
| | Ovulation | 1 | 2008 | 40 | 0.070 |
Why?
| | Luteal Phase | 1 | 2008 | 45 | 0.070 |
Why?
| | Cohort Studies | 1 | 2018 | 5742 | 0.070 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2013 | 683 | 0.070 |
Why?
| | Tomography, X-Ray Computed | 2 | 2018 | 2691 | 0.070 |
Why?
| | Quality of Life | 1 | 2018 | 2892 | 0.060 |
Why?
| | Fertility | 1 | 2007 | 160 | 0.060 |
Why?
| | Obesity | 2 | 2023 | 2992 | 0.060 |
Why?
| | Magnetic Resonance Imaging | 3 | 2017 | 3566 | 0.060 |
Why?
| | Embryo Transfer | 1 | 2004 | 32 | 0.060 |
Why?
| | Ovulation Induction | 1 | 2004 | 56 | 0.050 |
Why?
| | Mental Disorders | 1 | 2013 | 1077 | 0.050 |
Why?
| | Vasodilator Agents | 1 | 2006 | 331 | 0.050 |
Why?
| | Infertility | 1 | 2004 | 55 | 0.050 |
Why?
| | Piperazines | 1 | 2006 | 350 | 0.050 |
Why?
| | Carcinoembryonic Antigen | 1 | 2023 | 39 | 0.050 |
Why?
| | Succinate Dehydrogenase | 1 | 2023 | 50 | 0.050 |
Why?
| | Mice | 3 | 2025 | 17787 | 0.050 |
Why?
| | United States | 4 | 2025 | 14841 | 0.050 |
Why?
| | Ultrasonography | 1 | 2007 | 759 | 0.050 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2025 | 872 | 0.050 |
Why?
| | Otolaryngologists | 1 | 2022 | 13 | 0.050 |
Why?
| | Germ-Line Mutation | 1 | 2023 | 172 | 0.050 |
Why?
| | ErbB Receptors | 1 | 2025 | 614 | 0.050 |
Why?
| | Uterine Cervical Neoplasms | 1 | 2004 | 257 | 0.040 |
Why?
| | Parietal Lobe | 1 | 2021 | 58 | 0.040 |
Why?
| | Antineoplastic Agents | 1 | 2012 | 2129 | 0.040 |
Why?
| | Liver Cirrhosis | 1 | 2023 | 316 | 0.040 |
Why?
| | Illinois | 1 | 2020 | 43 | 0.040 |
Why?
| | Chicago | 1 | 2020 | 61 | 0.040 |
Why?
| | Tissue Adhesions | 1 | 2020 | 32 | 0.040 |
Why?
| | Hormones | 1 | 2020 | 143 | 0.040 |
Why?
| | Fertility Preservation | 1 | 2020 | 49 | 0.040 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2025 | 1396 | 0.040 |
Why?
| | NF-kappa B | 1 | 2023 | 691 | 0.040 |
Why?
| | Treatment Failure | 1 | 2020 | 356 | 0.040 |
Why?
| | Incidence | 1 | 2025 | 2804 | 0.040 |
Why?
| | Choice Behavior | 1 | 2020 | 170 | 0.040 |
Why?
| | Retroperitoneal Space | 1 | 2018 | 20 | 0.040 |
Why?
| | Abdominal Wall | 1 | 2018 | 24 | 0.040 |
Why?
| | Animals | 3 | 2025 | 36940 | 0.040 |
Why?
| | Gynecologic Surgical Procedures | 1 | 2018 | 63 | 0.040 |
Why?
| | Parity | 1 | 2018 | 126 | 0.030 |
Why?
| | Artificial Intelligence | 1 | 2021 | 279 | 0.030 |
Why?
| | Aging | 1 | 2008 | 1864 | 0.030 |
Why?
| | Endothelial Cells | 1 | 2023 | 785 | 0.030 |
Why?
| | Tumor Burden | 1 | 2018 | 309 | 0.030 |
Why?
| | Angiography, Digital Subtraction | 1 | 2016 | 44 | 0.030 |
Why?
| | Recurrence | 1 | 2020 | 1060 | 0.030 |
Why?
| | Drug Therapy | 1 | 2017 | 85 | 0.030 |
Why?
| | Insurance, Health | 1 | 2018 | 283 | 0.030 |
Why?
| | Positron Emission Tomography Computed Tomography | 1 | 2017 | 98 | 0.030 |
Why?
| | Radiotherapy | 1 | 2017 | 201 | 0.030 |
Why?
| | Promegestone | 1 | 2015 | 33 | 0.030 |
Why?
| | Molecular Targeted Therapy | 1 | 2019 | 411 | 0.030 |
Why?
| | Cell Line, Transformed | 1 | 2015 | 145 | 0.030 |
Why?
| | Practice Guidelines as Topic | 1 | 2023 | 1587 | 0.030 |
Why?
| | Aged, 80 and over | 2 | 2018 | 7635 | 0.030 |
Why?
| | United States Food and Drug Administration | 1 | 2015 | 208 | 0.030 |
Why?
| | Disease Management | 1 | 2019 | 628 | 0.030 |
Why?
| | Income | 1 | 2015 | 202 | 0.030 |
Why?
| | Liver | 1 | 2023 | 1943 | 0.030 |
Why?
| | Immunotherapy | 1 | 2019 | 641 | 0.030 |
Why?
| | Socioeconomic Factors | 1 | 2018 | 1289 | 0.030 |
Why?
| | Protein Isoforms | 1 | 2015 | 404 | 0.030 |
Why?
| | Educational Status | 1 | 2015 | 470 | 0.030 |
Why?
| | Endometrial Neoplasms | 1 | 2015 | 201 | 0.030 |
Why?
| | Databases, Factual | 1 | 2018 | 1357 | 0.020 |
Why?
| | Blotting, Western | 1 | 2015 | 1226 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2023 | 5757 | 0.020 |
Why?
| | Biopsy | 1 | 2015 | 1129 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2015 | 1738 | 0.020 |
Why?
| | Societies, Medical | 1 | 2015 | 820 | 0.020 |
Why?
| | Gels | 1 | 2010 | 80 | 0.020 |
Why?
| | Child, Preschool | 1 | 2025 | 11074 | 0.020 |
Why?
| | Adolescent | 2 | 2025 | 21513 | 0.020 |
Why?
| | Pregnanediol | 1 | 2008 | 16 | 0.020 |
Why?
| | Estrone | 1 | 2008 | 37 | 0.020 |
Why?
| | Decision Making | 1 | 2015 | 900 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2015 | 3556 | 0.020 |
Why?
| | Sildenafil Citrate | 1 | 2006 | 58 | 0.020 |
Why?
| | Sulfones | 1 | 2006 | 110 | 0.010 |
Why?
| | Purines | 1 | 2006 | 176 | 0.010 |
Why?
| | Women's Health | 1 | 2006 | 372 | 0.010 |
Why?
| | Prospective Studies | 1 | 2015 | 7604 | 0.010 |
Why?
|
|
Liu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|